MERTK role has been explored in a preclinical model, concluding that macrophages enriched in MERTK activate hepatic stellate cells in NASH by inducing TGF-β1 pathway therefore inducing liver fibrosis (87). The gene discussed is TGFB1; the disease is metabolic dysfunction-associated steatohepatitis.